To access this element change to forms mode OFF
Grant Award View - GA29875
Defining the anterograde and endocytic trafficking pathways in primary...
GA ID:
GA29875
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$674,920.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Defining the anterograde and endocytic trafficking pathways in primary neurons; relevance to dysfunctional trafficking of BACE1 and APP in Alzheimer's disease
Purpose:
Alzheimer’s disease results from toxic peptides arising from the cleavage of a large molecule called APP in the brain. The production of toxic peptides is normally regulated by the transport of APP molecules between compartments inside the cell. In Alzheimer’s disease, the APP transport pathways are altered leading to high levels of toxic peptide.This research will discover the basis for the altered transport of APP in disease, information which could allow new approaches for dementia treatment.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1163862
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA